| 联合用药对乙肝病毒标志物的影响 |
| |
| 引用本文： | 陈红.联合用药对乙肝病毒标志物的影响[J].甘肃科学学报,1998,10(4):62-63. |
| |
| 作者姓名： | 陈红 |
| |
| 作者单位： | 兰州医学院第一附属医院传染科 |
| |
| 摘 要： | 用特异性抗乙肝免疫核糖核酸（抗ＨＢ－ｉＲＮＡ）联合阿昔洛韦（ＡＣＶ）治疗慢性乙型肝炎１１３例，观察对乙肝病毒（ＨＢＶ）标志的影响，其结果表明：抗ＨＢ－ｉＲＮ联合ＡＣＶ对抑制或中和ＨＢＶ有一定作用。
|
| 关 键 词： | 阿昔洛韦 乙肝病毒 治疗 抗HB－iRNA 联合用药 |
THE INFLUENCE OF COMBINED MEDICATION ON HEPATITIS B HBV NOTATION |
| |
| Chen Hong.THE INFLUENCE OF COMBINED MEDICATION ON HEPATITIS B HBV NOTATION[J].Journal of Gansu Sciences,1998,10(4):62-63. |
| |
| Authors: | Chen Hong |
| |
| Abstract: | cases of chronic hepatitis B were treated with specific anti HB immune riboncleic acid (anti HB iRNA) and Acyclovir(ACV) for injection.The influence on HBV notation was observed. The study indicated that anti i HB iRNA and ACV play a certain role in the inhibition and neutralization of HBV. |
| |
| Keywords: | anti HB immune riboncleic acid(anti HB iRNA) Acyclovir for Injection (ACV) chronic hepatitis B HBV |
| 本文献已被 CNKI 维普 等数据库收录！ |
